22nd Nov 2007 07:01
Fabian Romania Limited22 November 2007 22 November 2007 Fabian Romania Limited (FAB.LN) Appointment of Joint Broker and financial PR firm Fabian Romania Limited ("Fabian" or the "Company"), the AIM quoted dedicatedRomanian real estate investor is pleased to announce the appointment of KBC PeelHunt Ltd as joint broker to the Company with immediate effect. KBC Peel Huntwill work alongside Fabian's current advisers, Deloitte Corporate Finance andShore Capital Stockbrokers Limited. KBC Peel Hunt is part of the KBC Group whichhas an extensive banking and investment banking presence throughout the CEEregion. Fabian is also pleased to announce the appointment of Monument PR as financialpublic relations advisers to the Company. Monument will work with the Company topublicise the Company's financial performance with the financial and propertypress in the UK and across continental Europe. Commenting on the appointments, Mark Holdsworth, Managing Director of FabianCapital, the Investment Adviser to Fabian said: "We are delighted to welcome KBC Peel Hunt as joint brokers to Fabian alongsideShore Capital. We are also very pleased to appoint Monument PR as the dedicatedpublic relations adviser to Fabian. Having two brokers and a financial PR firmworking with us will help communicate the positive valuation story behindFabian. In particular, we will seek, with their help, to widen our shareholderbase generally and especially target dedicated emerging European and Romanianinvestors as well as UK based small cap investors. These appointments mark thelatest stage in the Company's on-going investor relations strategy." Contacts:Fabian Capital LimitedMark Holdsworth Tel: +44 20 7499 9988 Deloitte Corporate Finance - Nominated Adviser to FabianJames Lewis Tel: +44 20 7936 3000 KBC Peel Hunt - Joint Broker to FabianCapel Irwin Tel: +44 20 7418 8900 Shore Capital Stockbrokers Limited - Joint Broker to FabianDru Danford Tel: +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Fusion Antibodies